BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36097589)

  • 21. Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer.
    Chen J; Li X; Huang C; Lin Y; Dai Q
    Technol Cancer Res Treat; 2020; 19():1533033820951807. PubMed ID: 33111646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of proteomic signatures associated with lung cancer and COPD.
    Pastor MD; Nogal A; Molina-Pinelo S; Meléndez R; Salinas A; González De la Peña M; Martín-Juan J; Corral J; García-Carbonero R; Carnero A; Paz-Ares L
    J Proteomics; 2013 Aug; 89():227-37. PubMed ID: 23665002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD.
    Wielscher M; Vierlinger K; Kegler U; Ziesche R; Gsur A; Weinhäusel A
    EBioMedicine; 2015 Aug; 2(8):929-36. PubMed ID: 26425700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of electroacupuncture on pulmonary neuroendocrine cells and secretion of neuroactive substances in lung of COPD rats].
    Wang CY; Su JC; Zhang XF; Cheng C; Zhang Y; Xiang SY; Liu WM; Zhang YJ; Xu SW; Liu ZB
    Zhen Ci Yan Jiu; 2022 Apr; 47(4):305-13. PubMed ID: 35486009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease patients: is systematic screening necessary?
    da Costa CH; Noronha Filho AJ; Marques E Silva RMF; da Cruz TF; de Oliveira Monteiro V; Pio M; Rufino RL
    BMC Res Notes; 2019 Jan; 12(1):10. PubMed ID: 30630519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.
    Bashir A; Shah NN; Hazari YM; Habib M; Bashir S; Hilal N; Banday M; Asrafuzzaman S; Fazili KM
    Respir Med; 2016 Aug; 117():139-49. PubMed ID: 27492524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DIAGNOSTIC AND TACTICAL IMPORTANCE OF STUDYING SHORT CHAIN FATTY ACIDS IN DIFFERENT BIOLOGICAL SUBSTRATES TOOK PLACE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LUNG CANCER AND COMMUNITY-ACQUIRED PNEUMONIA DEVELOPED AFTER ANTICANCER THERAPY.
    Ardatskaya MD; Ponomareva EV; Shevtsov VV; Evdokimova SA; Odintsov SV
    Eksp Klin Gastroenterol; 2016; (11):17-25. PubMed ID: 29889440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of
    Sangeetha T; Nargis Begum T; Balamuralikrishnan B; Arun M; Rengasamy KRR; Senthilkumar N; Velayuthaprabhu S; Saradhadevi M; Sampathkumar P; Vijaya Anand A
    J Renin Angiotensin Aldosterone Syst; 2022; 2022():2238320. PubMed ID: 36320441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency.
    Ferrari da Cruz T; Rufino R; Lopes AJ; Noronha A; Medeiros Anselmo F; Henrique da Costa C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2267-2274. PubMed ID: 33061344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protease inhibitor PI*S allele and COPD: a meta-analysis.
    Dahl M; Hersh CP; Ly NP; Berkey CS; Silverman EK; Nordestgaard BG
    Eur Respir J; 2005 Jul; 26(1):67-76. PubMed ID: 15994391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated circulating microRNA-126 in chronic obstructive pulmonary disease: linkage with acute exacerbation risk, severity degree, and inflammatory cytokines.
    Wang C; Feng D; Dong S; He R; Fan B
    J Clin Lab Anal; 2022 Mar; 36(3):e24204. PubMed ID: 35064606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function.
    Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D
    Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.
    Tessema M; Yingling CM; Picchi MA; Wu G; Liu Y; Weissfeld JL; Siegfried JM; Tesfaigzi Y; Belinsky SA
    J Thorac Oncol; 2015 Aug; 10(8):1181-8. PubMed ID: 26200272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer.
    Nader CP; Cidem A; Verrills NM; Ammit AJ
    Respir Res; 2019 Oct; 20(1):222. PubMed ID: 31623614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels and prognostic impact of circulating markers of inflammation, endothelial activation and extracellular matrix remodelling in patients with lung cancer and chronic obstructive pulmonary disease.
    Berg J; Halvorsen AR; Bengtson MB; Taskén KA; Mælandsmo GM; Yndestad A; Halvorsen B; Brustugun OT; Aukrust P; Ueland T; Helland Å
    BMC Cancer; 2018 Jul; 18(1):739. PubMed ID: 30005623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease.
    Chappell S; Daly L; Morgan K; Guetta Baranes T; Roca J; Rabinovich R; Millar A; Donnelly SC; Keatings V; MacNee W; Stolk J; Hiemstra P; Miniati M; Monti S; O'Connor CM; Kalsheker N
    Hum Mutat; 2006 Jan; 27(1):103-9. PubMed ID: 16278826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD).
    Ma H; Zhang Q; Zhao Y; Zhang Y; Zhang J; Chen G; Tan Y; Zhang Q; Duan Q; Sun T; Qi C; Li F
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1601-1612. PubMed ID: 35860812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.